Wagner Farid Gattaz
#138,888
Most Influential Person Now
Brasilian psychiatrist, researcher and university teacher
Wagner Farid Gattaz's AcademicInfluence.com Rankings
Download Badge
Biology
Wagner Farid Gattaz's Degrees
- Doctorate Psychiatry University of São Paulo
Why Is Wagner Farid Gattaz Influential?
(Suggest an Edit or Addition)Wagner Farid Gattaz's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 1: Update 2012 on the acute treatment of schizophrenia and the management of treatment resistance (2012) (495)
- World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 2: Update 2012 on the long-term treatment of schizophrenia and management of antipsychotic-induced side effects (2013) (346)
- Lithium and risk for Alzheimer's disease in elderly patients with bipolar disorder (2007) (331)
- Disease-modifying properties of long-term lithium treatment for amnestic mild cognitive impairment: randomised controlled trial (2011) (328)
- Causes and consequences of the gender difference in age at onset of schizophrenia. (1998) (327)
- Search for the Causes of Schizophrenia (1987) (314)
- Mental Disorders in Megacities: Findings from the São Paulo Megacity Mental Health Survey, Brazil (2012) (312)
- World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 1: Acute treatment of schizophrenia (2005) (301)
- Repetitive Transcranial Magnetic Stimulation for the Acute Treatment of Major Depressive Episodes: A Systematic Review With Network Meta-analysis (2017) (299)
- World Psychiatric Association Pharmacopsychiatry Section statement on comparative effectiveness of antipsychotics in the treatment of schizophrenia (2008) (277)
- Trial of Electrical Direct‐Current Therapy versus Escitalopram for Depression (2017) (230)
- Increased plasma phospholipase-A2 activity in schizophrenic patients: Reduction after neuroleptic therapy (1987) (211)
- The Epidemiology of Early Schizophrenia (1994) (196)
- Increased serum phospholipase A2 activity in schizophrenia: a replication study. (1990) (195)
- Transcranial magnetic stimulation accelerates the antidepressant effect of amitriptyline in severe depression: A double-blind placebo-controlled study (2005) (195)
- World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, Part 1: acute treatment of schizophrenia. (2005) (194)
- Prefrontal cortex shotgun proteome analysis reveals altered calcium homeostasis and immune system imbalance in schizophrenia (2009) (191)
- An animal model for the effects of estradiol on dopamine-mediated behavior: Implications for sex differences in schizophrenia (1991) (173)
- Increased Serum IL-1β Level in Alzheimer’s Disease and Mild Cognitive Impairment (2009) (168)
- Increased platelet phospholipase A2 activity in schizophrenia (1995) (164)
- Proteomic analysis of dorsolateral prefrontal cortex indicates the involvement of cytoskeleton, oligodendrocyte, energy metabolism and new potential markers in schizophrenia. (2009) (161)
- Stereologic investigation of the posterior part of the hippocampus in schizophrenia (2009) (149)
- Pain perception threshold in major depression (1993) (149)
- Cholesterol Modulates the Membrane- Disordering Effects of Beta-Amyloid Peptides in the Hippocampus: Specific Changes in Alzheimer’s Disease (2000) (143)
- Reduced cortical folding in schizophrenia: an MRI morphometric study. (2003) (140)
- Olanzapine versus ziprasidone: results of a 28-week double-blind study in patients with schizophrenia. (2005) (140)
- Alterations in oligodendrocyte proteins, calcium homeostasis and new potential markers in schizophrenia anterior temporal lobe are revealed by shotgun proteome analysis (2009) (140)
- Lithium increases plasma brain-derived neurotrophic factor in acute bipolar mania: A preliminary 4-week study (2011) (130)
- Vasopressin-oxytocin in cerebrospinal fluid of schizophrenic patients and normal controls (1985) (130)
- Oxidative stress in early stage Bipolar Disorder and the association with response to lithium. (2014) (129)
- Decreased Levels of Circulating Adiponectin in Mild Cognitive Impairment and Alzheimer’s Disease (2013) (127)
- Diagnosis and biomarkers of predementia in Alzheimer's disease (2010) (126)
- Does Lithium Prevent Alzheimer’s Disease? (2012) (125)
- Proteome analysis of schizophrenia patients Wernicke's area reveals an energy metabolism dysregulation (2009) (125)
- Amisulpride versus flupentixol in schizophrenia with predominantly positive symptomatology – a double-blind controlled study comparing a selective D2-like antagonist to a mixed D1-/D2-like antagonist (1998) (121)
- Effect of brain-derived neurotrophic factor Val66Met polymorphism and serum levels on the progression of mild cognitive impairment (2010) (113)
- The Bipolar Illness Onset study: research protocol for the BIO cohort study (2017) (111)
- World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia Part 3: Update 2015 Management of special circumstances: Depression, Suicidality, substance use disorders and pregnancy and lactation (2015) (109)
- Increased phospholipase A2 activity in schizophrenia with absent response to niacin (2003) (108)
- Effects of lithium on oxidative stress parameters in healthy subjects. (2011) (107)
- Lithium reduces Gsk3b mRNA levels: implications for Alzheimer Disease (2009) (106)
- Altered thalamic membrane phospholipids in schizophrenia: a postmortem study (2004) (106)
- Patterns of regional gray matter loss at different stages of schizophrenia: A multisite, cross-sectional VBM study in first-episode and chronic illness☆ (2016) (104)
- Insights into Alzheimer disease pathogenesis from studies in transgenic animal models (2011) (103)
- Comparison of repetitive transcranial magnetic stimulation and electroconvulsive therapy in unipolar non-psychotic refractory depression: a randomized, single-blind study. (2006) (101)
- Decreased phospholipase A2 activity in Alzheimer brains (1995) (97)
- Cholinergic and glutamatergic alterations beginning at the early stages of Alzheimer disease: participation of the phospholipase A2 enzyme (2008) (91)
- Proteome analysis of schizophrenia brain tissue (2010) (90)
- Efficacy and Safety of Transcranial Direct Current Stimulation as an Add-on Treatment for Bipolar Depression: A Randomized Clinical Trial (2017) (90)
- Higher serum sTNFR1 level predicts conversion from mild cognitive impairment to Alzheimer's disease. (2011) (89)
- BDNF blood levels after electroconvulsive therapy in patients with mood disorders: A systematic review and meta-analysis (2014) (88)
- The neuroprotective effect of dental pulp cells in models of Alzheimer’s and Parkinson’s disease (2008) (87)
- Diagnostic transitions in mild cognitive impairment subtypes (2009) (84)
- Reduced serum levels of adiponectin in elderly patients with major depression. (2012) (83)
- Cerebrospinal fluid biomarkers in Alzheimer's disease: Diagnostic accuracy and prediction of dementia (2015) (82)
- Increased platelet GSK3B activity in patients with mild cognitive impairment and Alzheimer's disease. (2011) (81)
- Profiles of functional deficits in mild cognitive impairment and dementia: benefits from objective measurement (2010) (81)
- The detection of depression in medical setting: a study with PRIME-MD. (2006) (81)
- Mild cognitive impairment: cognitive screening or neuropsychological assessment? (2008) (79)
- Influence of the menstrual cycle phase on the therapeutic response in schizophrenia (1994) (77)
- Clinical and biological effects of long-term lithium treatment in older adults with amnestic mild cognitive impairment: randomised clinical trial (2019) (74)
- Oestradiol enhances the vulnerability threshold for schizophrenia in women by an early effect on dopaminergic neurotransmission (1991) (71)
- Decreased Neurotrophic Support is Associated with Cognitive Decline in Non-Demented Subjects. (2015) (71)
- Taenia solium DNA is present in the cerebrospinal fluid of neurocysticercosis patients and can be used for diagnosis (2006) (70)
- Multidimensional analysis of the concentrations of 17 substances in the CSF of schizophrenics and controls (1985) (68)
- Bcl-2 rs956572 Polymorphism is Associated with Increased Anterior Cingulate Cortical Glutamate in Euthymic Bipolar I Disorder (2013) (68)
- Treatment of Bipolar Depression with Deep TMS: Results from a Double-Blind, Randomized, Parallel Group, Sham-Controlled Clinical Trial (2017) (67)
- Polymorphisms in genes involved in neurodevelopment may be associated with altered brain morphology in schizophrenia: Preliminary evidence (2009) (66)
- Decreased phospholipase A2 activity in the brain and in platelets of patients with Alzheimer's disease (2005) (65)
- Interleukin-1beta serum levels is increased in antidepressant-free elderly depressed patients. (2010) (65)
- Serum brain-derived neurotrophic factor level is reduced in antidepressant-free patients with late-life depression (2010) (65)
- World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 2: Long-term treatment of schizophrenia (2006) (65)
- Platelet MAO activity and personality characteristics (1981) (64)
- Phospholipase A2 activation as a therapeutic approach for cognitive enhancement in early-stage Alzheimer disease (2008) (64)
- Abnormalities in serum concentrations of interleukin-2, interferon-α and interferon-γ in schizophrenia not detected (1992) (63)
- Long-term, low-dose lithium treatment does not impair renal function in the elderly: a 2-year randomized, placebo-controlled trial followed by single-blind extension. (2014) (63)
- Circulating Glial-derived neurotrophic factor is reduced in late-life depression. (2012) (63)
- Reduced serum nerve growth factor in patients with late-life depression. (2012) (62)
- Psychiatric aspects of male genital self-mutilation. (1991) (62)
- Inhibition of calcium-independent phospholipase A2 activity in rat hippocampus impairs acquisition of short- and long-term memory (2005) (61)
- Altered Neurotrophin, Neuropeptide, Cytokines and Nitric Oxide Levels in Autism (2012) (61)
- Childhood meningitis, brain maturation and the risk of psychosis* (2004) (60)
- Decreased S100-beta protein in schizophrenia: preliminary evidence (2000) (60)
- CSF monoamine metabolites in schizophrenic patients (1982) (60)
- Vocational rehabilitation improves cognition and negative symptoms in schizophrenia (2011) (59)
- Decreased AKT1/mTOR pathway mRNA expression in short-term bipolar disorder (2015) (58)
- Efficacy and Safety of Transcranial Direct Current Stimulation for Treating Negative Symptoms in Schizophrenia: A Randomized Clinical Trial. (2020) (58)
- Neurotensin-like immunoreactivity in cerebrospinal fluid of patients with schizophrenia, depression, anorexia nervosa-bulimia, and premenstrual syndrome. (1989) (57)
- To treat or not to treat? A meta-analysis of the use of cholinesterase inhibitors in mild cognitive impairment for delaying progression to Alzheimer’s disease (2009) (57)
- The Short Cognitive Performance Test (SKT): a preliminary study of its psychometric properties in Brazil (2005) (57)
- Effects of β-amyloid peptides on the fluidity of membranes from frontal and parietal lobes of human brain. High potencies of Aβ1-42 and Aβ1-43 (1998) (57)
- Increased platelet membrane lysophosphatidylcholine in schizophrenia (1991) (55)
- Depressão e câncer (2009) (55)
- Clinical and biological predictors of Alzheimer's disease in patients with amnestic mild cognitive impairment. (2010) (55)
- Cytokines plasma levels during antidepressant treatment with sertraline and transcranial direct current stimulation (tDCS): results from a factorial, randomized, controlled trial (2014) (54)
- Dopamine and noradrenalin in the cerebrospinal fluid of schizophrenic patients (1983) (54)
- Mild cognitive impairment. Part 1: clinical characteristics and predictors of dementia. (2013) (54)
- Abnormal APP processing in platelets of patients with Alzheimer’s disease: correlations with membrane fluidity and cognitive decline (2007) (54)
- The value of REM sleep parameters in differentiating Alzheimer's disease from old-age depression and normal aging. (1998) (53)
- Platelet phospholipase A2 activity in Alzheimer’s disease and mild cognitive impairment (2004) (53)
- Relação entre consumo de drogas e comportamento sexual de estudantes de 2o grau de São Paulo (1999) (52)
- Increased soluble TNF receptor 2 in antidepressant-free patients with late-life depression. (2010) (51)
- The use of ASB-14 in combination with CHAPS is the best for solubilization of human brain proteins for two-dimensional gel electrophoresis. (2007) (50)
- Increased Brain Lactate During Depressive Episodes and Reversal Effects by Lithium Monotherapy in Drug-Naive Bipolar Disorder: A 3-T 1H-MRS Study (2017) (50)
- World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia – a short version for primary care (2017) (49)
- Cortical NMDA receptor properties and membrane fluidity are altered in Alzheimer's disease. (1996) (49)
- Conjugated estrogens as adjuvant therapy in the treatment of acute schizophrenia: a double-blind study (2004) (49)
- Bimodal Effect of Lithium Plasma Levels on Hippocampal Glutamate Concentrations in Bipolar II Depression: A Pilot Study (2015) (49)
- Reduced cerebrospinal fluid levels of brain-derived neurotrophic factor is associated with cognitive impairment in late-life major depression. (2014) (48)
- Childhood meningitis increases the risk for adult schizophrenia (2005) (47)
- Lithium increases leukocyte mitochondrial complex I activity in bipolar disorder during depressive episodes (2014) (46)
- HLA antigens and schizophrenia: A pool of two studies (1981) (46)
- Differences in the immune-inflammatory profiles of unipolar and bipolar depression. (2019) (46)
- Hypofrontality on topographic EEG in schizophrenia. Correlations with neuropsychological and psychopathological parameters. (1992) (46)
- Leukocyte mitochondrial DNA copy number in bipolar disorder (2014) (45)
- Antidepressant Efficacy of Adjunctive Aerobic Activity and Associated Biomarkers in Major Depression: A 4-Week, Randomized, Single-Blind, Controlled Clinical Trial (2016) (44)
- Lower Cerebrospinal Fluid Concentration of Brain-Derived Neurotrophic Factor Predicts Progression from Mild Cognitive Impairment to Alzheimer’s Disease (2015) (44)
- The more information, the more negative stigma towards schizophrenia: Brazilian general population and psychiatrists compared (2013) (44)
- Phospholipase A2 and the hypofrontality hypothesis of schizophrenia. (1996) (43)
- A Longitudinal (6-week) 3T 1H-MRS Study on the Effects of Lithium Treatment on Anterior Cingulate Cortex Metabolites in Bipolar Depression (2015) (43)
- The deleterious effect of ocular artefacts on the quantitative EEG, and a remedy (2005) (43)
- Inhibition of phospholipase A2 reduces neurite outgrowth and neuronal viability. (2007) (43)
- BDNF plasma levels after antidepressant treatment with sertraline and transcranial direct current stimulation: Results from a factorial, randomized, sham-controlled trial (2014) (42)
- Reduced phospholipid breakdown in Alzheimer’s brains: a 31P spectroscopy study (2005) (42)
- Low CSF Concentrations of Cyclic GMP in Schizophrenia (1983) (40)
- Olanzapine as Alternative Therapy for Patients With Haloperidol-Induced Extrapyramidal Symptoms: Results of a Multicenter, Collaborative Trial in Latin America (2001) (39)
- 31P-spectroscopy of frontal lobe in schizophrenia: alterations in phospholipid and high-energy phosphate metabolism (2002) (39)
- Cognitive outcomes of TMS treatment in bipolar depression: Safety data from a randomized controlled trial. (2018) (39)
- Hypofrontality on topographic EEG in schizophrenia (2005) (38)
- Lithium increases platelet serine-9 phosphorylated GSK-3β levels in drug-free bipolar disorder during depressive episodes. (2015) (38)
- Inhibition of phospholipase A2 activity reduces membrane fluidity in rat hippocampus (2005) (38)
- Reduced platelet amyloid precursor protein ratio (APP ratio) predicts conversion from mild cognitive impairment to Alzheimer’s disease (2012) (38)
- Association between BanI genotype and increased phospholipase A2 activity in schizophrenia (2007) (37)
- Stigma toward schizophrenia: do all psychiatrists behave the same? Latent profile analysis of a national sample of psychiatrists in Brazil (2013) (37)
- Platelet GSK3B activity in patients with late-life depression: Marker of depressive episode severity and cognitive impairment? (2011) (36)
- BDNF blood levels after non-invasive brain stimulation interventions in major depressive disorder: A systematic review and meta-analysis (2015) (36)
- Low serum levels of 25-hydroxyvitamin D (25-OHD) in children with autism. (2012) (35)
- Lack of association between schizophrenia and the phospholipase-A(2) genes cPLA2 and sPLA2. (2001) (35)
- Centella asiatica water extract inhibits iPLA2 and cPLA2 activities in rat cerebellum. (2008) (34)
- Assessment of non-BDNF neurotrophins and GDNF levels after depression treatment with sertraline and transcranial direct current stimulation in a factorial, randomized, sham-controlled trial (SELECT-TDCS): An exploratory analysis (2015) (34)
- Low angiotensin-converting enzyme activity (kininase II) in cerebrospinal fluid of schizophrenics. (1984) (33)
- Differential roles of phospholipases A2 in neuronal death and neurogenesis: Implications for Alzheimer disease (2010) (33)
- Lithium Decreases Plasma Adiponectin Levels in Bipolar Depression (2014) (32)
- Consensus paper of the WFSBP Task Force on Biological Markers: Criteria for biomarkers and endophenotypes of schizophrenia, part III: Molecular mechanisms (2017) (32)
- The role of phospholipase A2 in neuronal homeostasis and memory formation: implications for the pathogenesis of Alzheimer’s disease (2007) (32)
- COMT Met (158) modulates facial emotion recognition in bipolar I disorder mood episodes. (2012) (32)
- Plasma cortisol in first episode drug-naïve mania: differential levels in euphoric versus irritable mood. (2012) (32)
- Plasma biomarkers in a placebo-controlled trial comparing tDCS and escitalopram efficacy in major depression (2018) (31)
- Poverty, low education, and the expression of psychotic-like experiences in the general population of São Paulo, Brazil (2017) (31)
- Inhibition of platelet phospholipase A2 activity by catuaba extract suggests antiinflammatory properties (2004) (31)
- Requirement of hippocampal phospholipase A2 activity for long-term memory retrieval in rats (2007) (30)
- Platelet phospholipase A(2) activity in Alzheimer's disease and mild cognitive impairment. (2004) (29)
- Multidisciplinary rehabilitation program: effects of a multimodal intervention for patients with Alzheimer’s disease and cognitive impairment without dementia (2015) (29)
- Glutamate in schizophrenics and healthy controls (2004) (29)
- Allelic association analysis of phospholipase A2 genes with schizophrenia (2004) (28)
- Effects of antipsychotic treatment on membrane phospholipid metabolism in schizophrenia (2001) (28)
- Modulation of phospholipase A2 activity in primary cultures of rat cortical neurons (2005) (28)
- Body Mass Index Increase, Serum Leptin, Adiponectin, Neuropeptide Y and Lipid Levels during Treatment with Olanzapine and Haloperidol (2011) (28)
- Rightward cerebral asymmetry in subtypes of schizophrenia according to Leonhard's classification and to DSM-IV: a structural MRI study (2003) (28)
- Protein levels of ADAM10, BACE1, and PSEN1 in platelets and leukocytes of Alzheimer’s disease patients (2018) (27)
- REM sleep parameters in the discrimination of probable Alzheimer's disease from old-age depression (1993) (27)
- Home-Based Psychiatric Outpatient Care Through Videoconferencing for Depression: A Randomized Controlled Follow-Up Trial (2016) (27)
- Long-term lithium treatment increases intracellular and extracellular brain-derived neurotrophic factor (BDNF) in cortical and hippocampal neurons at subtherapeutic concentrations. (2016) (27)
- CT scans and neuroleptic response in schizophrenia: A multidimensional approach (1988) (27)
- Cognitive training increases platelet PLA2 activity in healthy elderly subjects. (2008) (27)
- Effects of haloperidol on somatostatin-like immuno-reactivity in the CSF of schizophrenic patients (1986) (27)
- Omega-3 consumption and sudden cardiac death in schizophrenia. (2009) (27)
- Cognitive impairment in late‐life bipolar disorder is not associated with Alzheimer's disease pathological signature in the cerebrospinal fluid (2016) (26)
- Elevated neurotrophin-3 and neurotrophin 4/5 levels in unmedicated bipolar depression and the effects of lithium (2015) (26)
- Inhibition of cPLA2 and sPLA2 Activities in Primary Cultures of Rat Cortical Neurons by Centella asiatica Water Extract (2012) (26)
- Formal Thought Disorder and language impairment in schizophrenia. (2012) (26)
- Antidepressant effects of tDCS are associated with prefrontal gray matter volumes at baseline: Evidence from the ELECT-TDCS trial (2019) (25)
- O estigma atribuído pelos psiquiatras aos indivíduos com esquizofrenia (2011) (25)
- Public stigmatization of different mental disorders: a comprehensive attitude survey (2012) (25)
- Inhibition of phospholipase A2 in rat brain decreases the levels of total Tau protein (2011) (25)
- Single-nucleotide polymorphisms of GSK3B, GAB2 and SORL1 in late-onset Alzheimer's disease: interactions with the APOE genotype (2013) (25)
- Ansiedade na performance musical: tradução, adaptação e validação do Kenny Music Performance Anxiety Inventory (K-MPAI) para a língua portuguesa (2011) (24)
- Transcranial direct current stimulation (tDCS) for preventing major depressive disorder relapse: Results of a 6‐month follow‐up (2019) (24)
- Moclobemide versus fluoxetine in the treatment of inpatients with major depression. (1995) (24)
- Effects of beta-amyloid peptides on the fluidity of membranes from frontal and parietal lobes of human brain. High potencies of A beta 1-42 and A beta 1-43. (1998) (24)
- Effects of antipsychotics with different weight gain liabilities on human in vitro models of adipose tissue differentiation and metabolism (2011) (24)
- Association of a new polymorphism in ALOX12 gene with bipolar disorder (2003) (24)
- Increased PLA2 activity in the hippocampus of patients with temporal lobe epilepsy and psychosis. (2011) (23)
- Increased plasma levels of soluble TNF receptors 1 and 2 in bipolar depression and impact of lithium treatment (2015) (23)
- Mild cognitive impairment. Part 2: Biological markers for diagnosis and prediction of dementia in Alzheimer's disease. (2013) (23)
- Melatonin immunoreactivity in cerebrospinal fluid of schizophrenic patients and healthy controls (1984) (23)
- Effects of zotepine, haloperidol and clozapine on MK-801-induced stereotypy and locomotion in rats (2005) (23)
- Diretrizes da Federação Mundial das Sociedades de Psiquiatria Biológica para o tratamento biológico da esquizofrenia. Parte 2: tratamento de longo prazo (2006) (23)
- Language impairment in euthymic, elderly patients with bipolar disorder but no dementia (2008) (23)
- Low platelet iPLA2 activity predicts conversion from mild cognitive impairment to Alzheimer’s disease: a 4-year follow-up study (2014) (23)
- Long-term decrease in immediate early gene expression after electroconvulsive seizures (2013) (22)
- Outcomes for Latin American Versus White Patients Suffering From Acute Mania in a Randomized, Double-Blind Trial Comparing Olanzapine and Haloperidol (2007) (22)
- Plasma levels of soluble TNF receptors 1 and 2 after tDCS and sertraline treatment in major depression: Results from the SELECT-TDCS trial. (2015) (22)
- Report of the WPA section of pharmacopsychiatry on the relationship of antiepileptic drugs with suicidality in epilepsy (2015) (22)
- Inhibition of phospholipase A2 in rat brain modifies different membrane fluidity parameters in opposite ways (2011) (22)
- [Cranial computed tomography in schizophrenia research]. (1981) (22)
- Childhood Adversity and Adult Onset of Hypertension and Heart Disease in São Paulo, Brazil (2013) (22)
- Increased cell proliferation in the rat anterior cingulate cortex following neonatal hypoxia: relevance to schizophrenia (2012) (22)
- Lithium increases nitric oxide levels in subjects with bipolar disorder during depressive episodes. (2014) (21)
- Conjugated linoleic acid-enriched butter improved memory and up-regulated phospholipase A2 encoding-genes in rat brain tissue (2015) (21)
- O estigma da esquizofrenia na mídia: um levantamento de notícias publicadas em veículos brasileiros de grande circulação (2012) (21)
- Patterns of stigma toward schizophrenia among the general population: A latent profile analysis (2014) (21)
- Basal ganglia abnormalities in tardive dyskinesia (1994) (21)
- Olanzapine versus flupenthixol in the treatment of inpatients with schizophrenia: a randomized double-blind trial. (2004) (21)
- Cognitive-linguistic deficits in euthymic elderly patients with bipolar disorder. (2013) (20)
- Differential effects of trimipramine and fluoxetine on sleep in geriatric depression. (2001) (20)
- Early improvement with lithium in classic mania and its association with later response. (2013) (20)
- Analysis of coding-polymorphisms in NOTCH-related genes reveals NUMBL poly-glutamine repeat to be associated with schizophrenia in Brazilian and Danish subjects (2006) (20)
- The evaluation of 4-hydroxy-3-methoxyphenylglycol sulfate as a possible marker of central norepinephrine turnover. Studies in healthy volunteers and depressed patients. (1988) (20)
- Erratum: The use of ASB-14 in combination with CHAPS is the best for solubilization of human brain proteins for two-dimensional gel electrophoresis (Briefings in Functional Genomics and Proteomics (2007) vol. 6 (70-75)) (2009) (19)
- Long-term sertraline treatment increases expression and decreases phosphorylation of glycogen synthase kinase-3B in platelets of patients with late-life major depression. (2012) (19)
- Increased brain membrane fluidity in schizophrenia. (2011) (19)
- Does BDNF genotype influence creative output in bipolar I manic patients? (2012) (19)
- Precision non-implantable neuromodulation therapies: a perspective for the depressed brain (2020) (19)
- Lithium Distinctly Modulates the Secretion of Pro- and Anti- Inflammatory Interleukins in Co-Cultures of Neurons and Glial Cells at Therapeutic and Sub-Therapeutic Concentrations. (2016) (19)
- Clinical patterns differentially predict response to transcranial direct current stimulation (tDCS) and escitalopram in major depression: A machine learning analysis of the ELECT-TDCS study. (2020) (19)
- Leukocyte telomerase activity and antidepressant efficacy in bipolar disorder (2014) (18)
- APOE Genotype and Alzheimer´s Disease (2000) (18)
- Kynurenine is correlated with IL-1β in plasma of schizophrenia patients (2018) (18)
- Chronic Lithium Treatment Increases Telomere Length in Parietal Cortex and Hippocampus of Triple-Transgenic Alzheimer's Disease Mice. (2018) (18)
- Abnormalities in serum concentrations of interleukin-2, interferon-alpha and interferon-gamma in schizophrenia not detected. (1992) (18)
- Nogo CAA 3′UTR Insertion polymorphism is not associated with Schizophrenia nor with bipolar disorder (2005) (18)
- Low platelet MAO activity and schizophrenia: sex differences (1981) (17)
- HLA ANTIGENS AND SCHIZOPHRENIA (1980) (17)
- USE OF PSYCHOACTIVE SUBSTANCES AND SEXUAL RISK BEHAVIOR IN ADOLESCENTS (2002) (17)
- Aripiprazole for Patients with Schizophrenia and Schizoaffective Disorder: An Open-Label, Randomized, Study Versus Haloperidol (2009) (17)
- Increased iPLA2 activity and levels of phosphorylated GSK3B in platelets are associated with donepezil treatment in Alzheimer’s disease patients (2015) (17)
- Recognition of Depressive Symptoms by Physicians (2009) (17)
- Lower doses of sublingual Zolpidem are more effective than oral Zolpidem to anticipate sleep onset in healthy volunteers. (2013) (17)
- Multifocal slow potential generation revealed by high-resolution EEG and current density reconstruction. (2002) (17)
- Inhibition of phospholipase A2 increases tau phosphorylation at Ser214 in embryonic rat hippocampal neurons. (2010) (16)
- Long-Term Lithium Treatment Increases cPLA2 and iPLA2 Activity in Cultured Cortical and Hippocampal Neurons (2015) (16)
- HLA-B27 as a possible genetic marker of psychoticism (1981) (16)
- Hippocampal serotonin depletion is related to the presence of generalized tonic–clonic seizures, but not to psychiatric disorders in patients with temporal lobe epilepsy (2015) (16)
- Long-term lithium treatment reduces glucose metabolism in the cerebellum and hippocampus of nondemented older adults: an [¹⁸F]FDG-PET study. (2014) (16)
- Hearing spirits? Religiosity in individuals at risk for psychosis—Results from the Brazilian SSAPP cohort (2019) (16)
- Multidimensional analysis of the concentrations of 17 substances in the CSF of schizophrenics and controls (2002) (15)
- Fluoxetine versus trimipramine in the treatment of depression in geriatric patients. (2005) (15)
- Plasma lipids metabolism in mild cognitive impairment and Alzheimer’s disease (2019) (15)
- Violencia e doenca mental: fato ou ficcao? (1999) (15)
- Cardiovascular effects of fluvoxamine and maprotiline in depressed patients (2005) (15)
- Loss of interest, depressed mood and impact on the quality of life: Cross-sectional survey (2011) (15)
- Mental healthcare in South America with a focus on Brazil: past, present, and future (2016) (15)
- Molecular size distribution of somatostatin-like immunoreactivity in the cerebrospinal fluid of patients with degenerative brain disease (1986) (14)
- Vitamin E attenuates the development of haloperidol-induced dopaminergic hypersensitivity in rats: possible implications for tardive dyskinesia (2005) (14)
- Donepezil effects on cholesterol and oxysterol plasma levels of Alzheimer’s disease patients (2018) (14)
- A possible association between HLA B-27 and vulnerability to schizophrenia (1985) (14)
- Haloperidol increases the cerebrospinal fluid concentrations of cyclic GMP in schizophrenic patients. (1984) (14)
- SHORT COMMUNICATION: Apolipoprotein E genotype and Cognition in Bipolar Disorder (2010) (14)
- Phospholipase A2 activity in rat embryonic brain and in primary cultures of cortical neurons (2002) (14)
- Uso de drogas entre estudantes de uma escola pública de São Paulo (2001) (14)
- Diurnal variability of orofacial dyskinetic movements. (1999) (13)
- Alterations of Brain Membranes in Schizophrenia: Impact of Phospholipase A2 (2012) (13)
- Association of BDNF, HTR2A, TPH1, SLC6A4, and COMT polymorphisms with tDCS and escitalopram efficacy: ancillary analysis of a double-blind, placebo-controlled trial (2019) (13)
- Acute and subchronic effects of low-dose bromocriptine in haloperidol-treated schizophrenics (1989) (13)
- Disclosing the diagnosis of schizophrenia: A pilot study of the ‘Coming Out Proud’ intervention (2019) (13)
- Complex slow potential generators in a simplified attention paradigm. (2006) (13)
- Computer Tomographic Studies in Schizophrenia (1990) (13)
- Lithium efficacy in bipolar depression with flexible dosing: A six-week, open-label, proof-of-concept study (2014) (13)
- Stereological investigation of the CA1 pyramidal cell layer in untreated and lithium-treated 3xTg-AD and wild-type mice. (2017) (13)
- Early improvement of psychotic symptoms with lithium monotherapy as a predictor of later response in mania. (2012) (13)
- The generators of slow potentials obtained during verbal, pictorial and spatial tasks. (2003) (13)
- Regulation of leukocyte tricarboxylic acid cycle in drug-naïve Bipolar Disorder (2015) (12)
- Bromocriptine in the treatment of neuroleptic-resistant schizophrenia (1986) (12)
- Decreased plasmatic spermidine and increased spermine in mild cognitive impairment and Alzheimer’s disease patients (2019) (12)
- Proteome analysis of human dorsolateral prefrontal cortex using shotgun mass spectrometry. (2008) (12)
- Intracerebral injection of phospholipase A2 inhibits dopamine-mediated behavior in rats: Possible implications for schizophrenia (2005) (12)
- Münchhausen syndrome: psychopathology and management. (1990) (12)
- Protein Expression of BACE1 is Downregulated by Donepezil in Alzheimer's Disease Platelets. (2016) (11)
- DNA polymorphisms as tools for spinal cord injury research (2009) (11)
- Three plasma metabolites in elderly patients differentiate mild cognitive impairment and Alzheimer’s disease: a pilot study (2019) (11)
- Alterations of brain membranes in schizophrenia: impact of phospholipase A(2). (2012) (11)
- Epistasis between COMT Val158Met and DRD3 Ser9Gly polymorphisms and cognitive function in schizophrenia: genetic influence on dopamine transmission. (2015) (11)
- Benefits of psychodynamic group therapy on depression, burden and quality of life of family caregivers to Alzheimer’s disease patients (2015) (11)
- A psychiatric unit in a general hospital in Brazil: predictors of length of stay (1992) (11)
- Guidelines for biological Treatment of Schizophrenia, : Part 1: Acute Treatment of Schizophrenia and Part 2: Long-term Treatment of Schizophrenia (2005) (11)
- Cytochrome P450 genotypes are not associated with refractoriness to antipsychotic treatment (2015) (11)
- Alpha-tocopherol in the treatment of tardive dyskinesia (1992) (11)
- Widespread electrical cortical dysfunction in schizophrenia (2004) (11)
- Structural Brain Abnormalities in Schizophrenia: An Integrative Model (1987) (11)
- Lithium activates brain phospholipase A2 and improves memory in rats: implications for Alzheimer’s disease (2016) (10)
- Lower phosphorylated glycogen synthase kinase-3B levels in platelets of patients with schizophrenia: increment by olanzapine treatment (2015) (10)
- Pioneering ambient mass spectrometry imaging in psychiatry: Potential for new insights into schizophrenia (2016) (10)
- Quantification of tryptophan in plasma by high performance liquid chromatography (2012) (10)
- The Absence of CYP3A5*3 Is a Protective Factor to Anticonvulsants Hypersensitivity Reactions: A Case-Control Study in Brazilian Subjects (2015) (10)
- Cognitive changes after tDCS and escitalopram treatment in major depressive disorder: Results from the placebo-controlled ELECT-TDCS trial. (2019) (10)
- Advances in Schizophrenia Research 2009 (2010) (10)
- Phospholipase A2 in Schizophrenia (1992) (10)
- Exploring the knowledge contained in neuroimages: Statistical discriminant analysis and automatic segmentation of the most significant changes (2010) (9)
- Reduced activities of phospholipases A2 in platelets of drug-naïve bipolar disorder patients. (2015) (9)
- Increased CSF cortisol levels after neuroleptic treatment in schizophrenia (1985) (9)
- Biochemical and Neuropathological Indices for the Aetiology of Schizophrenia (1987) (9)
- Oestrogen-A Protective Factor in Schizophrenia? (2006) (9)
- Glycogen synthase kinase‐3β in patients with bipolar I disorder: results from a prospective study (2016) (9)
- A radioenzymatic assay to identify three groups of phospholipase A(2) in platelets. (2012) (9)
- Balance of the Century (1999) (8)
- Intracerebroventricular injection of phospholipase A2 inhibits apomorphine-induced locomotion in rats (1995) (8)
- ARTHROPATHIES AND SCHIZOPHRENIA (1980) (8)
- Relative bioavailability of two oral formulations of risperidone 2 mg: A single-dose, randomized-sequence, open-label, two-period crossover comparison in healthy Brazilian volunteers. (2010) (8)
- Platelet MAO activity in major psychoses. (1983) (8)
- Repetitive Transcranial Magnetic Stimulation for the Acute Treatment of Major Depressive Episodes (2016) (8)
- Magnesium and calcium in the CSF of schizophrenic patients and healthy controls: correlations with cyclic GMP. (1983) (8)
- [Münchhausen syndrome: diagnosis and management]. (2003) (7)
- BDNF blood levels after electroconvulsive therapy in patients with mood disorders: An updated systematic review and meta-analysis (2022) (7)
- Correlation between platelet and brain PLA(2) activity. (2013) (7)
- Acute hormonal changes after IV citalopram and treatment response in OCD (2007) (7)
- Assessment of tardive dyskinesia by means of digital image processing (2005) (7)
- The schizophrenia stigma and mass media: a search for news published by wide circulation media in Brazil (2017) (7)
- Thalamic nuclear abnormalities as a contributory factor in sudden cardiac deaths among patients with schizophrenia (2010) (7)
- Effects of tDCS on neuroplasticity and inflammatory biomarkers in bipolar depression: Results from a sham-controlled study (2020) (7)
- 5‐hydroxytryptamine1A receptor density in the hippocampus of patients with temporal lobe epilepsy is associated with disease duration (2017) (7)
- Auditory evoked potentials in schizophrenic patients before and during neuroleptic treatment (1993) (7)
- Conditioning training and retrieval increase phospholipase A2 activity in the cerebral cortex of rats (2008) (7)
- Estradiol attenuates dopamine-mediated behavior in rats. Implications for sex differences in schizophrenia (1992) (7)
- Antipsychotic drugs decrease iPLA2 gene expression in schizophrenia (2013) (6)
- Relação entre consumo de drogas e comportamento sexual de estudantes de 2 o grau de São Paulo* Relationship between drug consumption and sexual behavior among high school students of São Paulo (1999) (6)
- MK-801 induced stereotypies in rats are decreased by haloperidol and increased by diazepam (2005) (6)
- Cortical surface abnormalities are different depending on the stage of schizophrenia: A cross-sectional vertexwise mega-analysis of thickness, area and gyrification (2021) (6)
- Auditory evoked potentials in schizophrenic patients before and during neuroleptic treatment. Relationship to psychopathological state (1992) (6)
- Oral tardive dyskinesia: validation of a measuring device using digital image processing (2005) (6)
- Digital movement analysis, a new objective method of measuring tardive dyskinesia and drug-induced parkinsonian tremor: acceptability, reliability and validity (2005) (6)
- [Estradiol inhibits dopamine mediated behavior in rats--an animal model of sex-specific differences in schizophrenia]. (1992) (6)
- Fatty acid and phospholipase A2 plasma levels in children with autism. (2013) (6)
- [Accelerated breakdown of membrane phospholipids in schizophrenia--implications for the hypofrontality hypothesis]. (1994) (6)
- [Possible involvement of phospholipase A2 in the pathogenesis of schizophrenia]. (1990) (6)
- Nanotubos de carbono aplicados às neurociências: perspectivas e desafios (2011) (6)
- Cognitive outcomes of the bipolar depression electrical treatment trial (BETTER): a randomized, double-blind, sham-controlled study (2020) (5)
- Algumas recomendações para estudos com placebo (2000) (5)
- Glycogen Synthase Kinase-3β: Variation over Time and the Possible Association with Mood and Cognition in Healthy Individuals (2016) (5)
- BDNF Val66Met polymorphism is not related with temporal lobe epilepsy caused by hippocampal sclerosis in Brazilian population (2018) (5)
- Topographic abnormality of slow cortical potentials in schizophrenia. (2004) (5)
- EEG alpha peak frequency analysis during memorizing of figures in patients with mild cognitive impairment. (2009) (5)
- Diagnosis and biomarkers of predementia in (2010) (5)
- DONEPEZIL MODULATES ADAM10 AND BACE1 EXPRESSION IN PLATELETS OF ALZHEIMER'S DISEASE PATIENTS (2016) (5)
- Switching from oral risperidone to flexibly dosed oral paliperidone extended-release: core symptoms, satisfaction, and quality of life in patients with stable but symptomatic schizophrenia: the RISPALI study (2014) (5)
- Influência de mecanismos colinérgicos nos processos neurodegenerativos relacionados à formação de amilóide e à fosforilação da proteína tau (2000) (4)
- Phenylethylamine and monoamine metabolites in CSF of schizophrenics: Effects of neuroleptic treatment (2005) (4)
- Reduced Annexin A3 in schizophrenia (2019) (4)
- Accelerated Breakdown of Platelet Membrane Phospholipids in Schizophrenia (1992) (4)
- Phenylethylamine and phenylacetic acid in CSF of schizophrenics and healthy controls (1982) (4)
- Cerebrospinal fluid concentrations of free GABA in schizophrenia: No changes after haloperidol treatment (2005) (4)
- [Biologic artifacts in quantitative EEG]. (2006) (4)
- [Antipsychotics and phospholipid metabolism in schizophrenia]. (2001) (4)
- Synergistic and additive effects of enriched environment and lithium on the generation of new cells in adult mouse hippocampus (2014) (4)
- Do Human Erythrocyte Membranes Contain Muscarinic Cholinergic Receptors (1986) (4)
- Prefrontal resting-state connectivity and antidepressant response: no associations in the ELECT-TDCS trial (2020) (4)
- Cognitive outcomes after tDCS in schizophrenia patients with prominent negative symptoms: Results from the placebo-controlled STARTS trial (2021) (4)
- The effect of rivastigmine on sleep in elderly healthy subjects [Experimental Gerontology 35 (2000) 243–249] (2000) (4)
- Prevalência de depressão em mulheres idosas com fratura de quadril (2009) (3)
- Is schizophrenia disappearing? (1991) (3)
- Glycogen synthase kinase-3β activity and cognitive functioning in patients with bipolar I disorder (2018) (3)
- Higher transcription alleles of the MAOA-uVNTR polymorphism are associated with higher seizure frequency in temporal lobe epilepsy (2019) (3)
- Estudos de neuroimagem na classificacao de Leonhard (2002) (3)
- Plasmatic endocannabinoids are decreased in subjects with ultra‐high risk of psychosis (2021) (3)
- Plasma metabolites in first episode psychoses (2019) (3)
- [Relevance of metabolism of membrane phospholipids for Alzheimer dementia]. (1996) (3)
- Low platelet PLA2 activity predicts conversion from mild cognitive impairment to Alzheimer's disease: A 4-year follow-up study (2013) (3)
- Chronic inhibition of brain phospholipase A2 in adult rats impairs the survival of newborn mature neurons in the hippocampus (2015) (3)
- Phospholipase A2 and hypofrontality in schizophrenia (1996) (3)
- Lithium and neuroprotection: new potential uses in psychiatry (2007) (3)
- Influence of migration on the thought process of individuals at ultra-high risk for psychosis (2020) (3)
- Exacerbation of psychosis risk during the COVID-19 pandemic: The disproportionate impact on the lower income population (2021) (3)
- Estabilidade intra-individual dos parâmetros obtidos pela espectroscopia de fósforo do encéfalo (1999) (3)
- O uso do lítio em idosos: evidências de sua ação neuroprotetora (2002) (3)
- Relationship Between Symptomatic Dimensions and Global Functioning of Non-Help-Seeking Individuals at Risk for Psychosis. (2020) (3)
- Low-dose pergolide in the treatment of tardive dyskinesia (TD): A double-blind, placebo-controlled randomized cross-over trial (1999) (2)
- Tardive dyskinesia: Recognition and quantification by means of digital image processing (1992) (2)
- Childhood meningitis and adult schizophrenia (2004) (2)
- Cold weather and risk of sudden cardiac death in schizophrenia: finding a new Achilles' heel? (2008) (2)
- Motion energy analysis during speech tasks in medication-naïve individuals with at-risk mental states for psychosis (2022) (2)
- Schizophrenia TreAtment with electRic Transcranial Stimulation (STARTS): design, rationale and objectives of a randomized, double-blinded, sham-controlled trial. (2019) (2)
- Temporal stability of auditory evoked potentials at different stimulation rates. (1994) (2)
- An early psychosis research program in São Paulo, Brazil: Organization and implementation (2008) (2)
- HLA-Antigens, Schizophrenia and Brain Atrophy (1980) (2)
- [Tardive dyskinesia: pergolid, a possible therapeutic option]. (2003) (2)
- CSF Studies in Schizophrenia: A Multidimensional Approach (1985) (2)
- Does vitamin E prevent tardive dyskinesia? (1995) (2)
- Effects of the menstrual cycle on therapeutic response in schizophrenic patients (1992) (2)
- The HLA system and schizophrenia (1980) (2)
- A double blind placebo controlled study of conjugated estrogens added to haloperidol in patients with schizophrenia (2001) (2)
- Increased PLA2 activity in individuals at ultra-high risk for psychosis (2021) (2)
- [The isolated olfactory hallucinosis and the olfactory hallucinations in the endogenous psychoses (author's transl)]. (1982) (2)
- HLA, Schizophrenien und Arthropathien (1981) (2)
- Increased phospholipase A2 activity in schizophrenia (1992) (2)
- Increased platelet glycogen sysnthase kinase 3beta in first-episode psychosis (2017) (2)
- COX-2 pathway is upregulated in ultra-high risk individuals for psychosis (2021) (2)
- The role of lithium treatment on comorbid anxiety symptoms in patients with bipolar depression. (2022) (2)
- T203. ILLICIT DRUGS USE AND ULTRA-HIGH RISK (UHR) FOR PSYCHOSIS STATUS IN A LATIN-AMERICAN SAMPLE (2018) (2)
- Tomografia cerebral computadorizada e esquizofrenia: revisão crítica da literatura (1988) (2)
- Functional impairment prevalence in Brazilian frailty elderly (2011) (2)
- Cholinesterase inhibitors increase iPLA2 activity in platelets of patients with Alzheimer's disease (2012) (1)
- Decreased platelet phospholipase A2 activity in Alzheimer's disease and mild cognitive Impairment (2004) (1)
- Lithium Affects Cortical and Subcortical Volume in Bipolar Depressed Patients (2022) (1)
- P3-229: GAB2, GSTP1 and GAPDH polymorphisms and their potential role in late-onset Alzheimer's disease (2008) (1)
- Increased lysophosphatidylcholine content in platelet membrane of schizophrenics (1992) (1)
- Vitamin E Attenuates the Development of Neuroleptic‐Induced Dopaminergic Hypersensitivity in Rats: Implications for Tardive Dyskinesia (1992) (1)
- Reversal of microstructural white matter changes in drug-naive patients with first-episode psychosis after antipsychotic treatment (2014) (1)
- Correction: The Absence of CYP3A5*3 Is a Protective Factor to Anticonvulsants Hypersensitivity Reactions: A Case-Control Study in Brazilian Subjects (2015) (1)
- PLATELET APP RATIO IN AD PATIENTS TREATED WITH DONEPEZIL (2014) (1)
- Erratum to Proteomic analysis of dorsolateral prefrontal cortex indicates the involvement of cytoskeleton, oligodendrocyte, energy metabolism and new potential markers in schizophrenia [Journal of Psychiatric Research (2009); 43(11): 978–86] (2011) (1)
- P0341 - Memantine induces expression of PLA2 genes in rat brain: Possible implications for reverse learning and memory of Alzheimer's disease patients (2008) (1)
- Diretrizes da Federação Mundial das Sociedades de Psiquiatria Biológica para o tratamento biológico da esquizofrenia. Parte 2: tratamento de longo prazo World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia. Part 2: long-term treatment (2006) (1)
- LIPID METABOLITE PLASMA LEVELS AS BIOMARKERS OF EARLY-ONSET ALZHEIMER DISEASE (2017) (1)
- A criminalização do doente mental: como fazer e como evitar (1999) (1)
- Classificacao das psicoses endogenas de Karl Leonhard (1998) (1)
- SPERMINE AS A POTENTIAL PERIPHERAL BIOMARKER OF MILD COGNITIVE IMPAIRMENT AND ALZHEIMER’S DISEASE (2017) (1)
- Long-term sertraline treatment increases expression and phosphorilation of glycogen synthase kinase-3B in platelets of patients with late-life major depression (2012) (1)
- S193. EFFICACY AND SAFETY OF TRANSCRANIAL DIRECT CURRENT STIMULATION FOR TREATING NEGATIVE SYMPTOMS IN SCHIZOPHRENIA: THE FOLLOW-UP PHASE (2020) (1)
- Polymorfism Of CYP2C9 And 3A5 and carbamazepine hypersensitivity reactions in Brazilian subjects (2014) (1)
- Activity of phospholipase A2 (PLA2) subtypes in rat brain is altered by feeding conjugated linoleic acid (CLA) and linseed oil (2009) (1)
- Alzheimer’s Disease-related Biomarkers in Aging Adults with Down Syndrome: Systematic Review (2019) (1)
- Addressing Mood Disorder Diagnosis' Stigma With an Honest, Open, Proud (HOP)-Based Intervention: A Randomized Controlled Trial (2021) (1)
- What Does Proteomics Tell Us About Schizophrenia (2011) (1)
- [The histocompatibility system in schizophrenia]. (1982) (1)
- Childhood maltreatment in individuals at risk of psychosis: Results from the Brazilian SSAPP cohort (2020) (1)
- Lítio crônico potencializa a sobrevivência de novas células induzida por enriquecimento ambiental no hipocampo de camundongos adultos* Chronic lithium potentiates enrichment-induced survival of new cells in the hippocampus of adult mice (2013) (1)
- Inhibition of phospholipase A2 modulates glycogen synthase kinase (GSK) activity and Tau phosphorylation in primary cultures of cortical and hippocampal neurons (2009) (1)
- ESTRADIOL ATTENUATES DOPAMINE-MEDIATED BEHAVIOR IN RATS: IMPLICATIONS FOR SEX DIFFERENCES IN SCHIZOPHRENIA (1992) (1)
- [Cerebral computed tomography and schizophrenia: a critical review of the literature]. (1988) (1)
- Alprazolam response in major depression: relationship with urinary levels of MHPG-sulfate. (1988) (1)
- T204. Treatment of Negative Symptoms of Schizophrenia With tDCS (Transcranial Direct Current Stimulation): A Randomized, Sham-Controlled, Double-Blinded Clinical Trial (2018) (1)
- Urinary MHPG-sulfate and urinary MHPG-glucuronide, two possible markers of the central or peripheral norepinephrine metabolism in man. The effect of alprazolam treatment. (1988) (1)
- Profi les of functional defi cits in mild cognitive impairment and dementia: benefi ts from objective measurement (2010) (1)
- Prevalence of cognitive impairment in Brazilian frailty elderly (2011) (1)
- Environmental risk factors of psychosis (2002) (1)
- Administrative influences on psychiatric diagnosis (1988) (1)
- Antipsychotics preserve telomere length in peripheral blood mononuclear cells after acute oxidative stress injury (2021) (1)
- A randomized clinical trial of home-based telepsychiatric outpatient care via videoconferencing: design, methodology, and implementation (2015) (1)
- Lithium increases leukocyte mitochondrial complex I activity in bipolar disorder during depressive episodes (2014) (1)
- Reduced platelet amyloid precursor protein ratio (APP ratio) predicts conversion from mild cognitive impairment to Alzheimer's disease (2012) (1)
- Abnormal phospholipid metabolism in Alzheimer's disease: 31P-spectroscopy study of the pre-frontal cortex (2004) (1)
- Serum nerve growth factor (NGF) level is reduced in mild cognitive impairment and Alzheimer's disease (2011) (1)
- Repetitive Transcranial Magnetic Stimulation in Augmentation of Antidepressant Drugs (2007) (1)
- Genetic and Proteomic Studies in Schizophrenia (2010) (1)
- Latency increase of auditory-evoked potential component N1 predicts poor neuroleptic response in schizophrenic patients. (1994) (1)
- Network Meta-analysis in Mental Health Treatment Research-Reply. (2017) (0)
- Front & Back Matter (2016) (0)
- 39-105 Increased membrane phospholipid reakdown in schizoiphrenic patients during neuroleptic treatment (1997) (0)
- Clinical and biological predictors of Alzheimer's disease in patients with amnestic mild cognitive impairment Preditores clínicos e biológicos da evolução para doença de Alzheimer em pacientes com comprometimento cognitivo leve amnéstico (2009) (0)
- Response (1987) (0)
- Cholinergic drug downregulates annexin A3 in platelets of Alzheimer’s Disease patients (2022) (0)
- Alpha-tocopherol attenuates the development of neuroleptic-induced dopaminergic hypersensitivity in rats. Implications for tardive dyskinesia (1992) (0)
- Front & Back Matter (2015) (0)
- P.5.b.001 The role of hippocampal phospholipase A2 in memory retrieval in rats (2006) (0)
- Phospholipase A 2 hemmt die dopaminerge Neurotransmission bei Ratten in vivo (1996) (0)
- Cognitive Patterns and Conversion in a Representative Sample of Individuals at Risk for Psychosis (2021) (0)
- Efeito da adição do estrógeno conjugado em pacientes esquizofrênicas em tratamento com haloperidol: estudo duplo-cego (2001) (0)
- Novo estabelecimento de ensaios radioreceptores D1 e D2 em substância cinzenta de cérebro humano (2003) (0)
- Contents Vol. 28, 2009 (2010) (0)
- LITHIUM TREATMENT PREVENTS AMYLOID TOXICITY AND MIR-489 DOWN-REGULATION IN AN ALZHEIMER’S DISEASE IN VITRO MODEL (2016) (0)
- Assessment of association cortex activity by high-resolution EEG and current density reconstruction (2000) (0)
- Acknowledgement to referees (2008) (0)
- REM Sleep Criteria - Putative Markers for Distinction of Alzheimer's Disease and Major Depression (1995) (0)
- P1-366: Glycogen synthase kinase activity in platelets of patients with Alzheimer's disease, mild cognitive impairment and controls (2008) (0)
- Proteomic Characterization of the Brain and Cerebrospinal Fluid of Schizophrenia Patients (2014) (0)
- Association between anxiety, depression and cognitive dysfunction in patients with multiple sclerosis (0)
- Childhood abuse and family violence in relation to adult onset of hypertension and heart disease in São Paulo, Brazil (2013) (0)
- P3-067 Brazilian version of the Short Cognitive Performance Test (SKT) - psychometric properties and diagnostic accuracy in Alzheimer’s disease (AD) and mild cognitive impairment (MCI) (2006) (0)
- DONEPEZIL EFFECTS ON CHOLESTEROL AND OXYESTEROLS PLASMA LEVELS OF ALZHEIMER’S DISEASE PATIENTS (2017) (0)
- Leonhard´s classification of Schizophrenias and MRI brain abnormalities: preliminary results (1999) (0)
- Auditory Evoked Potentials and Rrediction of Short‐Term Neuroleptic Response in Schizophrenia (1992) (0)
- Subject Index Vol. 28, 2009 (2010) (0)
- Lower Cerebrospinal Fluid Concentration of Brain-Derived Neurotrophic Factor Predicts Progression from Mild Cognitive Impairment to Alzheimer’s Disease (2015) (0)
- Pattern of proteolytic processing of Amyloid Precursor Protein in Down syndrome (2021) (0)
- Testes de rastreio cognitive vs. bateria neuropsicológica na identificação do compromentimento cognitvo leve e seus subtipos (2008) (0)
- P2-391: Lithium inhibits GSK3β transcription in hippocampal neurons and human leukocytes (2008) (0)
- Alzheimer's disease: Donepezil effects on cholesterol and oxysterol plasma levels (2020) (0)
- Decision tree-based classification as a support to diagnosis in the Alzheimer’s disease continuum using cerebrospinal fluid biomarkers: insights from automated analysis (2022) (0)
- Front & Back Matter (2015) (0)
- P3-035: Bipolar disorder in old age: Prospective evaluation of cognitive functions (2008) (0)
- Platelet APP levels from subjects with Alzheimer’s disease and mild cognitive impairment (2020) (0)
- Long-term lithium treatment for patients with mild cognitive impairment: Benefits on cognition and evidence of disease modification (2010) (0)
- P3-349: Cognitive training increases platelet PLA2 activity in healthy elderly subjects (2008) (0)
- Brain-derived neurotrophic factor serum level is reduced in mild cognitive impairment and Alzheimer's disease (2009) (0)
- Activity of PLA2 Forms in Primary Neuronal Cultures (2007) (0)
- Corrigendum to cytochrome P450 genotypes are not associated with refractoriness to antipsychotic treatment [Schizophr. Res. 168 (2015) 587–588] (2016) (0)
- Inhibition of phospholipase A2 modulates glycogen synthase kinase (GSK) activity and Tau phosphorylation in primary cultures of cortical and hippocampal neurons (2009) (0)
- Chronic inhibition of brain phospholipase A2 in rats as a model to investigate Alzheimer-related alterations: a preliminary study (2007) (0)
- The Bipolar Illness Onset study (2017) (0)
- A Longitudinal MRI-study of the Effects of Lithium on Cortical Thickness and Brain Volume and its association with Clinical Response in Bipolar Disorder (2019) (0)
- Cytokines plasma levels during antidepressant treatment with sertraline and transcranial direct current stimulation (tDCS): results from a factorial, randomized, controlled trial (2013) (0)
- S109. Antidepressant Effects of TDCS are Associated With Prefrontal Grey Matter Volumes at Baseline: Evidence From the ELECT-tDCS Trial (2019) (0)
- Lithium increases cortical and subcortical volumes in subjects with bipolar disorder (2022) (0)
- Genetic polymorphisms of the serotonin transporter are not related with depression in temporal lobe epilepsy caused by hippocampal sclerosis (2021) (0)
- Editorial announcement regarding new impact factor and title change (2014) (0)
- A new editorial board for new challenges (2017) (0)
- PROTEOME ANALYSES OF POST-MORTEM BRAIN TISSUE FROM PATIENTS WITH SCHIZOPHRENIA SUGGEST DYSFUNCTION OF OLIGODENDROCYTES AND ASTROCYTES AND POTENTIAL BIOMARKER CANDIDATES? (2012) (0)
- F42. COGNITIVE PATTERNS ASSOCIATED WITH CHILDHOOD TRAUMA AND RISK FOR PSYCHOSIS IN A POPULATIONAL SAMPLE–A LATENT PROFILE ANALYSIS (2019) (0)
- Shotgun proteome analysis of schizophrenia brain tissue (2008) (0)
- Mild cognitive impairment: cognitive screening or neuropsychological assessment? Comprometimento cognitivo leve: rastreio cognitivo ou avaliação neuropsicológica? (2008) (0)
- SU21 INTEGRATED ANALYSIS OF MICROARRAY AND PROTEOMICS DATA BY HIPPOCAMPAL RAT NEURONS AND HUMAN IPS NEURONS TREATED WITH DIFFERENT DOSES OF LITHIUM (2019) (0)
- Cytokines analysis in therapeutic and sub-therapeutic lithium-treated primary neuron and glia co-culture (2013) (0)
- Meeting report: The Schizophrenia International Research Society (SIRS) South America Conference (August 5–7, 2011) (2012) (0)
- S131. PERCEPTUAL ABNORMALITIES AND RELIGIOSITY IN ULTRA HIGH-RISK FOR PSYCHOSIS (UHR) INDIVIDUALS IN A LATIN AMERICAN POPULATIONAL SAMPLE RESULTS FROM THE SAO PAULO SSAPP COHORT (2018) (0)
- Application of Lipidomics in Psychiatry: Plasma-Based Potential Biomarkers in Schizophrenia and Bipolar Disorder (2023) (0)
- Protein levels of APP, ADAM10 and BACE1 in aging adults with Down syndrome: Preliminary findings (2020) (0)
- Society of biological psychiatry (1994) (0)
- Poster #T231 ANTI-PSYCHOTIC TREATMENT DECREASED IPLA2 ACTIVITY IN FIRST EPISODE DRUG NAIVE PATIENTS (2014) (0)
- Decreased Levels of Circulating Adiponectin in Mild Cognitive Impairment and Alzheimer’s Disease (2012) (0)
- ' s response to reviews Title : Pre-dementia in Alzheimer ' s disease (2010) (0)
- CSF brain-derived neurotrophic factor (BDNF) is reduced in preclinical Alzheimer's disease (2010) (0)
- Poster #M23 ANTIPSYCHOTIC TREATMENT DECREASED IPLA2 ACTIVITY IN FIRST EPISODE DRUG NAÏVE PATIENTS WITH SCHIZOPHRENIA (2014) (0)
- Translation and validation of the Structured Interview for Prodromal Syndromes (SIPS) to Portuguese (2021) (0)
- Poster #M20 INCREASED GLYCOGEN SYNTHASE KINASE-3B (GSK-3B) EXPRESSION IN PLATELETS OF FIRST ONSET PSYCHOSIS NON-AFFECTIVE PATIENTS (2014) (0)
- Treatment of negative symptoms of schizophrenia with transcranial direct current stimulation (tDCS): clinical, randomized, sham-controlled, double-blind Researchers: (2019) (0)
- PLASMATIC METABOLITES PREDICT CONVERSION FROM MILD COGNITIVE IMPAIRMENT TO ALZHEIMER’S DISEASE (2017) (0)
- Poster #S139 PLA2 GENE EXPRESSION IN FIRST EPISODE DRUG NAIVE PATIENTS (2014) (0)
- Phospholipase A2 inhibition in the rat hippocampus disrupts short- and long-term memory processing (2004) (0)
- Inibição da fosfolipase 'A IND. 2' e hiperfosforilação da proteína Tau em culturas primárias de neurônios corticais e hipocampais (2007) (0)
- 30 anos da Revista de Psiquiatria Clínica (2003) (0)
- Atividade de subtipos de 'PLA IND. 2' em neurônios primários mantidos em cultura (2007) (0)
- GSK3beta em plaquetas de indivíduos com doença de Alzheimer e comprometimento cognitivo leve (2007) (0)
- Tardive dyskinesia: preclinical and clinical aspects (2005) (0)
- O aprendizado e a evocação de uma tarefa contextual aumentam atividade da fosfolipase 'A IND.2' no córtex parietal associativo de ratos (2007) (0)
- Motor Disorders in Alzheimer?s Disease and Mild Cognitive Impairment (2007) (0)
- P3-340: PLA2 enzyme: New target for memantine action (2008) (0)
- Da arte de fazer ciência e de comer jabuticabas - uma homenagem ao Prof. Dr. Ricardo Renzo Brentani (2012) (0)
- Brasileiros estudam prevenção contra Alzheimer (1999) (0)
- Alterações no Corpo Editorial da RPC (2006) (0)
- Three plasma metabolites in elderly patients differentiate mild cognitive impairment and Alzheimer’s disease: A mass spectrometry study (2020) (0)
- Platelet PLA2 activity in patients with mild cognitive impairment: a longitudinal study (2011) (0)
- Social-economic profile of a Brazilian frailty elderly sample (2011) (0)
- Looking back on a prosperous year 2014 (2014) (0)
- LOW DOSES OF LITHIUM CHANGE PKA, AKT AND TAU PROTEIN IN CORTICAL AND HIPPOCAMPAL NEURONS CELL CULTURE (2014) (0)
- A liberdade cura? Relato a proposito da "psiquiatria democratica" na Italia (1979) (0)
- Authors' reply (2007) (0)
- Disturbances in Motor Dexterity Performance as Predictor for Neuroleptic Extrapyramidal Side Effects in Schizophrenia (1992) (0)
- Lithium increases mitochondrial function in cultured hippocampal neurons (2011) (0)
- Effects of the Menstrual Cycle on the Therapeutic Response in Schizophrenia (1992) (0)
- Molecular modeling and structural analysis of the Myelin basic protein-Q65ZS4. (2007) (0)
- P4-167 Inhibition of phospholipase A2 in neurons: effects of neurite outgrowth and viability (2004) (0)
- Use of a Bayesian Network Model to predict psychiatric illness in individuals with ‘at risk mental states’ from a general population cohort (2021) (0)
- REM SLEEP REGULATION IN DEMENTIA OF THE ALZHEIMER TYPE AND OLD‐AGE DEPRESSION (1992) (0)
- 897. Association between Childhood Adversity and Ultra-High Risk for Psychosis Status in a Populational Sample of Sao Paulo, Brazil (2017) (0)
- Contents of volume 250 · 2000 (2000) (0)
- [HLA-system in psychiatric research (author's transl)]. (1981) (0)
- Serum concentrations of interleukin-2, interferon-alpha and interferon-gamma in schizophrenia: Failure to detect abnormalities (1992) (0)
- SA61. Association Between Childhood Adversity and Ultra-High Risk for Psychosis Status in a Populational Sample of Sao Paulo, Brazil (2017) (0)
- Assimilating knowledge from neuroimages in schizophrenia diagnostics (2008) (0)
- Dr. Paul Janssen (1926-2003) (2003) (0)
- EFFECT OF CHRONIC LITHIUM TREATMENT ON TELOMERIC LENGTH IN TRIPLE-TRANSGENIC ALZHEIMER'S DISEASE MICE (2016) (0)
- Dopamine receptor D2 genetic polymorphism associated with transition to mental disorders in a cohort of individuals with at-risk mental state for psychosis. (2023) (0)
- Membrane Abnormalities in Psychotic Disorders (2003) (0)
- P.4.11 Specific alterations of brain membranes in schizophrenia (2004) (0)
- Disturbances in motor dexterity performance of schizophrenic patients as predictor for the manifestation of extrapyramidal side effects during neuroleptic treatment (1992) (0)
- P2-150: Inhibition of phospholipase A2 increases phosphorylation of tau in primary cultures of hippocampal neurons (2008) (0)
- Front & Back Matter (2014) (0)
- P3-126: Diagnostic properties of the short cognitive performance test in screening for mild cognitive impairment and Alzheimer's disease (2008) (0)
- Spontaneous speech in Alzheimer type, multi-infarct, and depressive “pseudo”-dementia (1989) (0)
- Treatment of Patients with Recently Exacerbated Schizophrenia with Paliperidone Palmitate: A Pilot Study of Efficacy and Tolerability (2020) (0)
- Decreased PLA2‐activity in platelets of paraoxone poisoned mini pigs (1996) (0)
- Treatment of depression in the elderly with repetitive transcranial magnetic stimulation using theta-burst stimulation: Study protocol for a randomized, double-blind, controlled trial (2022) (0)
- Low doses of lithium increased intra- and extracellular brain-derived neurotrophic factor (BDNF) and tumor necrosis factor (TNF) α in cortical and hippocampal neuron cell culture (2013) (0)
- [HLA, schizophrenias and arthropathies]. (1981) (0)
- Corrigendum to “The detection of depression in medical setting: A study with PRIME-MD” [Journal of Affective Disorders 91/1 (2006) 11–17] (2006) (0)
- Relationship between 31P-NMR spectroscopy and neuropsychological performance in schizophrenia (2004) (0)
- PROTEOMIC ANALYSIS OF HIPPOCAMPAL CELL CULTURE WITH LOW DOSES OF LITHIUM TREATMENT (2016) (0)
- P3-124 The influence of lithium on the risk of Alzheimer's disease (2004) (0)
- Long-term treatment with cholinesterase inhibitors restores homeostatic levels of calcium-independent PLA2: Evidence of disease-modification in Alzheimer's disease (2013) (0)
- Regular physical activity in a healthy elderly population is associated with lower peripheral iPLA2 activity (2013) (0)
- APOE-ε4 interaction with single-nucleotide polymorphisms and risk for Alzheimer's disease (2012) (0)
- Increased Lysophosphatidylcholine in Platelet Membrane from Schizophrenics (1992) (0)
- Search for the Causes of Schizophrenia - Vol 5 (2004) (0)
- Platelet APP‐ratio correlates with CSF levels of Aβ1‐42 in Alzheimer’s disease patients (2020) (0)
- P4-138 Cognitive impairment in the elderly with bipolar disorder - influence of language disturbances (2006) (0)
- Author's reply (2011) (0)
- Detecting At-Risk Mental States for Psychosis (ARMs) in General Population Individuals Using Machine Learning Ensembles and Facial Features (2022) (0)
- Specific alterations of brain membranes in schizophrenia (2004) (0)
- Polymorfism Of CYP2C9 And 3A5 and carbamazepine hypersensitivity reactions in Brazilian subjects (2014) (0)
- Inhibition of PLA2 inactivates GSK3B via Akt and CAMKII in primary cultures of hippocampal neurons (2012) (0)
- Effects of neuroleptic therapy on phospholipid metabolism in schizophrenia (1992) (0)
- Treino de memória aumenta a atividade de 'PLA IND. 2' em plaquetas (2007) (0)
- A radioenzymatic assay for the determination of phospholipase A2 in serum suitable for psychiatric and non-psychiatric patients. (1988) (0)
- T51. TREATMENT OF NEGATIVE SYMPTOMS OF SCHIZOPHRENIA WITH TRANSCRANIAL CURRENT STIMULATION (TDCS): RESULTS OF RANDOMIZED, DOUBLE-BLINDED, SHAM-CONTROLLED TRIAL (2018) (0)
- Human leukocyte antigen genotype in antiepileptics hypersensitivity reactions: a pilot study in Brazilian patients (2013) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Wagner Farid Gattaz?
Wagner Farid Gattaz is affiliated with the following schools:
